MiNA Therapeutics kicks off first-ever PhI saRNA nanoparticle trial
Fierce Biotech,
The small U.K. biotech MiNA Therapeutics has begun the first human trial of a small activating RNA drug to help liver cancer…
Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo
Overview of attention for article published in Hepatology, December 2013
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
High Attention Score compared to outputs of the same age and source (92nd percentile)
Mentioned by
- news
- 1 news outlet
- 5 X users
- patent
- 19 patents
- wikipedia
- 4 Wikipedia pages
- f1000
- 1 research highlight platform
Readers on
- mendeley
- 107 Mendeley
- citeulike
- 1 CiteULike